Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3502

Actual shortage: 231 (7%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3257 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ELETRIPTAN 20MG TABLET Resolved 2017-03-10 2020-01-07 305
APO-DORZO-TIMOP 5MG 20MG SOLUTION Resolved 2017-03-10 2019-07-13 290
APO-DILTIAZ CD 300MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2017-03-10 2018-12-18 287
APO-DILTIAZ CD 180MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2017-03-10 2018-12-18 284
APO-DILTIAZ CD 120MG CAPSULE (CONTROLLED-DELIVERY) Resolved 2017-03-10 2018-12-18 281
APO-DESMOPRESSIN 0.2MG TABLET Resolved 2017-03-10 2017-06-21 278
APO-DESMOPRESSIN 0.1MG TABLET Resolved 2017-03-10 2017-05-13 275
APO-VALSARTAN 80MG TABLET Resolved 2017-03-10 2019-03-08 272
APO-VALSARTAN/HCTZ 12.5MG 160MG TABLET Resolved 2017-03-10 2019-03-21 269
APO-VALSARTAN/HCTZ 12.5MG 80MG TABLET Resolved 2017-03-10 2019-03-21 266
APO-VALSARTAN/HCTZ 12.5MG 160MG TABLET Resolved 2017-03-10 2019-03-21 263
APO-VERAP SR 180MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-10 2019-12-04 260
APO-VERAP SR 240MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-10 2019-12-04 255
APO-VORICONAZOLE 200MG TABLET Resolved 2017-03-10 2017-03-15 252
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-17 249
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-10 245
APO-CYCLOSPORINE ORAL SOLUTION 100MG SOLUTION Resolved 2017-03-10 2018-09-09 241
APO-CLINDAMYCIN 300MG CAPSULE Resolved 2017-03-10 2017-10-30 122
APO-CLINDAMYCIN 150MG CAPSULE Resolved 2017-03-10 2017-05-27 119
APO-CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-10 2017-05-05 116

Showing 3461 to 3480 of 3502

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMITRIPTYLINE 75MG TABLET To be discontinued 2025-01-10 2025-01-10 247472
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2025-01-10 2025-01-27 247469
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2025-01-10 2025-01-11 247466
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2025-01-10 2025-01-11 247462
APO-CARVEDILOL 25MG TABLET Discontinued 2024-01-26 2024-01-27 217504
APO-CARVEDILOL 6.25MG TABLET To be discontinued 2024-01-26 2024-01-26 217499
APO-CARVEDILOL 3.125MG TABLET To be discontinued 2024-01-26 2024-01-26 217496
APO-CARVEDILOL 12.5MG TABLET To be discontinued 2024-01-26 2024-08-06 217493
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Discontinued 2023-09-26 2023-11-02 205310
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 150MG 300MG TABLET Discontinued 2022-12-12 2022-12-12 177953
APO-CLOBETASOL SPRAY 0.05% SPRAY Discontinued 2022-09-06 2022-09-06 168648
APO-BICALUTAMIDE 50MG TABLET Discontinued 2022-03-25 2022-05-13 157376
MELPHALAN FOR INJECTION 10ML 50MG POWDER FOR SOLUTION KIT SOLUTION Discontinued 2022-03-23 2022-03-23 157136
APO-PINDOL TAB 15MG 15MG TABLET Discontinued 2022-02-09 2022-12-09 154574
APO-PINDOL TAB 10MG 10MG TABLET Discontinued 2022-02-09 2022-02-10 154571
APO-PINDOL TAB 5MG 5MG TABLET Discontinued 2022-02-09 2022-02-10 154568
APO-QUETIAPINE 25MG TABLET Discontinued 2021-06-25 2021-06-25 141546
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950
APO-AMOXI SUGAR FREE 250MG POWDER FOR SUSPENSION Discontinued 2020-06-22 2020-06-22 118526

Showing 1 to 20 of 359